688606 logo

Hangzhou Alltest Biotech Co., Ltd. Stock Price

SHSE:688606 Community·CN¥5.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

688606 Share Price Performance

CN¥67.44
-9.95 (-12.86%)
CN¥67.44
-9.95 (-12.86%)
Price CN¥67.44

688606 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet second-rate dividend payer.

3 Risks
1 Reward

Hangzhou Alltest Biotech Co., Ltd. Key Details

CN¥911.3m

Revenue

CN¥0

Cost of Revenue

CN¥911.3m

Gross Profit

CN¥693.0m

Other Expenses

CN¥218.3m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 20, 2026
2.79
100.00%
23.95%
0.2%
View Full Analysis

About 688606

Founded
2009
Employees
960
CEO
Fei Gao
WebsiteView website
www.alltests.com.cn

Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters. In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products. Its products are used in clinical testing, on-site testing, personal health management, and other fields. Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China.

Recent 688606 News & Updates

Recent updates

No updates